Please Wait.....
Report
UAE Human Insulin Market By Indication (Type I Diabetes, Type II Diabetes), By Route of Administration (Subcutaneous, Nasal, Intravenous, Transdermal, Oral and Others), By Type (Basal, Bolus, Pre-mixed, Biosimilar, Traditional), By Onset Time (Rapid Acting, Short-Acting, Intermediate Acting, Long Acting, Ultra-long Acting, Pre-Mixed, Inhaled), By Products (Insulin Pens, Insulin Pumps, Infusion System, Injection), By Region, Competition Forecast & Opportunities, 2027
Market Report I 2023-02-01 I 79 Pages I TechSci Research
UAE human insulin market is anticipated to register growth with an impressive CAGR in the forecast period, 2023-2027, on the account of increasing instances of diabetes among the population of the country. Growing advancement in the pharmaceutical industry and surging demand for pharmaceutical products to control high blood sugar levels among the population are further driving the growth of the UAE human insulin market in the upcoming five years. Moreover, the increasingly sedentary lifestyle of the adult and young adult population that give rise to the lifestyle diseases like obesity, blood pressure, and blood sugar disorders, also facilitates the growth of the UAE human insulin market in the next five years.
Synthetic insulin designed and manufactured in laboratories is known as human insulin. In the laboratories, human insulin is created by growing the insulin proteins in Escherichia Coli (E-Coli) bacteria and later deriving the insulin from bacteria. The bacterial culture is grown under a controlled environment maintaining the hygiene and purity of the bacterial culture. Before the discovery of human insulin, animal insulin was used in a purified form of porcine (swine/pigs). Human insulin is majorly available in two forms regular insulin and Neutral Protamine Hagedorn insulin.
Diabetes Instances Drive Market Growth
Increasing instances of diabetes among the population of the country is the most important factor driving the growth of the UAE human insulin market in the upcoming five years. In the year 2021, among every 1000 population mark of the country, over 990 people suffer from diabetes. The cases of diabetes are higher among the geriatric population of the country. One in every 5 people aged over 69 years suffers from diabetes in the country. By 2019, over 19% of the adult population aged between 20 years to 79 years were suffering from type II diabetes. The country stands at the 10th largest population suffering from diabetes on the world scale.
Experts even mention diabetes as a silent pandemic in the country since the death count because of diabetes is much higher as compared to COVID-19. People suffering from diabetes were strictly advised to monitor their health conditions before and after vaccination since the immune system of a diabetic patient is drastically affected. Thus, increasing the risks of COVID-19 infection multiple folds.
Pharma Advancement For Insulin Drug Delivery Promises Growth
Research and product development is taking place in the country. The government is aiding the research institutes and pharmaceutical designers to advance the drugs and drug delivery systems such that efficient insulin delivery systems can be deduced, which would further aid the growth of the UAE human insulin market in the upcoming five years.
Trabolsi Research Group at NYU Abu Dhabi has developed a revolutionary technology in insulin oral delivery system that can orally administer insulin and avoid side effects caused by the otherwise process of subcutaneous delivery of insulin through frequent injection. The researchers have developed gastro-resistant imine-linked-covalent organic framework nanoparticles (nCOFs) by using prepared layers of nanosheets with insulin loaded in between layers. The system is biocompatible, highly stable in the stomach, specific, and able to deliver the right amount of insulin. Thus, providing a future scope for further development and enhancing the market growth along with it.
Market Segmentation
The UAE human insulin market is segmented by indication, route of administration, type, onset time, products, competitional landscape, and regional distribution. Based on indication, the market is differentiated between type I diabetes and type II diabetes. By route of administration, the market is fragmented into subcutaneous, nasal, intravenous, transdermal, oral, and others. Based on type, the market is further segmented into basal, bolus, pre-mixed, biosimilar, and traditional. The onset time market segment is further defined into rapid-acting, short-acting, intermediate-acting, long-acting, ultra-long acting, pre-mixed, and inhaled. Based on products, the market is bifurcated into insulin pens, insulin pumps, infusion systems, and injection. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among Abu Dhabi region, Dubai region, Sharjah region, and the rest of UAE.
Company Profile
Novo Nordisk Pharma Gulf FZ-LLC, Sanofi UAE, Baxter International UAE, B. Braun Medical Gulf FZ - LLC, Eli Lilly, and Company UAE, Becton Dickinson And Company UAE, Gulf Pharmaceutical Industries P.S.C. (Julphar), among others is a partial list of major market players of the companies responsible for the growth of UAE human insulin market.
Report Scope:
In this report, UAE human insulin market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- UAE Human Insulin Market, By Indication:
o Type I Diabetes
o Type II Diabetes
- UAE Human Insulin Market, By Route of Administration:
o Subcutaneous
o Nasal
o Intravenous
o Transdermal
o Oral
o Others
- UAE Human Insulin Market, By Type:
o Basal
o Bolus
o Pre-mixed
o Biosimilar
o Traditional
- UAE Human Insulin Market, By Onset Time:
o Rapid Acting
o Short-Acting
o Intermediate Acting
o Long Acting
o Ultra-long Acting
o Pre-Mixed
o Inhaled
- UAE Human Insulin Market, By Product:
o Insulin Pens
o Insulin Pumps
o Infusion System
o Injection
- UAE Human Insulin Market, By Region:
o Abu Dhabi
o Dubai
o Sharjah
o Rest of the UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in UAE human insulin market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on UAE Human Insulin Market
4. Voice of Customer
5. Executive Summary
6. UAE Human Insulin Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Indication (Type I Diabetes, Type II Diabetes)
6.2.2. By Route of Administration (Subcutaneous, Nasal, Intravenous, Transdermal,
Oral and Others)
6.2.3. By Type (Basal, Bolus, Pre-mixed, Biosimilar, Traditional)
6.2.4. By Onset Time (Rapid Acting, Short-Acting, Intermediate Acting, Long Acting, Ultra-long Acting, Pre-Mixed, Inhaled)
6.2.5. By Products (Insulin Pens, Insulin Pumps, Infusion System, Injection)
6.2.6. By Company (2021)
6.2.7. By Region
6.3. Product Market Map
7. Dubai Human Insulin Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Indication
7.2.2. By Route of Administration
7.2.3. By Type
7.2.4. By Onset Time
7.2.5. By Products
8. Sharjah Human Insulin Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Indication
8.2.2. By Route of Administration
8.2.3. By Type
8.2.4. By Onset Time
8.2.5. By Products
9. Abu Dhabi Human Insulin Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Indication
9.2.2. By Route of Administration
9.2.3. By Type
9.2.4. By Onset Time
9.2.5. By Products
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
12. Policy & Regulatory Landscape
13. UAE Economic Profile
14. Competitive Landscape
14.1. Competition Outlook
14.2. Company Profiles
14.2.1. Novo Nordisk Pharma Gulf FZ-LLC
14.2.2. Sanofi UAE
14.2.3. Baxter International UAE
14.2.4. B. Braun Medical Gulf FZ - LLC
14.2.5. Eli Lilly and Company UAE
14.2.6. Becton Dickinson And Company UAE
14.2.7. Gulf Pharmaceutical Industries P.S.C. (Julphar)
15. Strategic Recommendations
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security